Chemical Formula: C25H38O8

Chemical Formula C25H38O8

Found 73 metabolite its formula value is C25H38O8

Androsterone glucuronide

(2S,3S,4S,5R,6R)-6-{[(1S,2S,5R,7S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2567)


Androsterone glucuronide (ADT-G) is one of the major circulating C19-steroid metabolites in humans. Human and monkey are unique in having high levels of circulating ADT-G. Furthermore, the plasma levels of these glucuronide derivatives reflect the peripheral tissue conversion of adrenal and gonadal precursor C19-steroids to active androgens in various pathophysiological conditions. Identification and characterization of human UDP-glucuronosyltransferase 2B (UGT2Bs) demonstrated the major role that these enzymes play in androgen conjugation, with UGT2B15 and UGT2B17 (EC 2.4.1.17) being the major androsterone-conjugating isoforms. Exaggerated androsterone metabolism, is observed in hyper-androgenic as well as in some normo-androgenic women with acne and androsterone glucuronide could be a marker in differentiating acne and hirsutism in hyperandrogenic women. Present data shows that the most practical and probably only valid means of assessing androgenic activity in women is to measure ADT-G, the metabolite that accounts for 93\\% of the total androgen glucuronide derivatives. (PMID: 12943709, 12445184, 16621522) [HMDB] Androsterone glucuronide (ADT-G) is one of the major circulating C19-steroid metabolites in humans. Human and monkey are unique in having high levels of circulating ADT-G. Furthermore, the plasma levels of these glucuronide derivatives reflect the peripheral tissue conversion of adrenal and gonadal precursor C19-steroids to active androgens in various pathophysiological conditions. Identification and characterization of human UDP-glucuronosyltransferase 2B (UGT2Bs) demonstrated the major role that these enzymes play in androgen conjugation, with UGT2B15 and UGT2B17 (EC 2.4.1.17) being the major androsterone-conjugating isoforms. Exaggerated androsterone metabolism, is observed in hyper-androgenic as well as in some normo-androgenic women with acne and androsterone glucuronide could be a marker in differentiating acne and hirsutism in hyperandrogenic women. Present data shows that the most practical and probably only valid means of assessing androgenic activity in women is to measure ADT-G, the metabolite that accounts for 93\\% of the total androgen glucuronide derivatives. (PMID: 12943709, 12445184, 16621522). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

5β-Androstan-3α-ol-17-One Glucosiduronate

(2S,3S,4S,5R,6R)-6-{[(1S,2S,5R,7R,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2567)


Etiocholanolone glucuronide is a natural human metabolite of etiocholanolone generated in the liver by UDP glucuonyltransferase. Etiocholanolone (or 5-isoandrosterone) is a metabolite of testosterone. Classified a ketosteroid, it causes fever, immunostimulation and leukocytosis. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] Etiocholanolone glucuronide is a natural human metabolite of etiocholanolone generated in the liver by UDP glucuonyltransferase. Etiocholanolone (or 5-isoandrosterone) is a metabolite of testosterone. Classified a ketosteroid, it causes fever, immunostimulation and leukocytosis. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Etiocholanolone glucuronide. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=3602-09-3 (retrieved 2024-06-29) (CAS RN: 3602-09-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

5-alpha-Dihydrotestosterone glucuronide

(2S,3S,4S,5R,6R)-6-{[(1S,2S,7S,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2567)


5-alpha-Dihydrotestosterone glucuronide is a natural human metabolite of 5alpha-Dihydrotestosterone generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 5-alpha-Dihydrotestosterone glucuronide is a natural human metabolite of 5alpha-Dihydrotestosterone generated in the liver by UDP glucuonyltransferase. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide

(3S,5R,6S)-6-{[(1S,2S,5R,7S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2567)


3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide is a natural human metabolite of 3-alpha-hydroxy-5-alpha-androstane-17-one generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.

   

5alpha-Androstan-17beta-ol-3-one glucosiduronate

6-({2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2567)


   

DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,6R,7Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C25H38O8 (466.2567)


DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5S,6S,7Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C25H38O8 (466.2567)


DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C25H38O8 (466.2567)


DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C25H38O8 (466.2567)


DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Mniopetal B

Mniopetal B

C25H38O8 (466.2567)


   

Mniopetal D

Mniopetal D

C25H38O8 (466.2567)


   

Leucasdin A

Leucasdin A

C25H38O8 (466.2567)


   

(1S,2S,3R,4R,6R)-diangeloyloxy-3,4-epoxy-2,10,11-trihydroxybisabol-7(14)-ene|1beta,8-diangeloyloxy-3beta,4beta-epoxy-2beta,10,11-trihydroxybisabol-7(14)-ene

(1S,2S,3R,4R,6R)-diangeloyloxy-3,4-epoxy-2,10,11-trihydroxybisabol-7(14)-ene|1beta,8-diangeloyloxy-3beta,4beta-epoxy-2beta,10,11-trihydroxybisabol-7(14)-ene

C25H38O8 (466.2567)


   

Asebotoxin IX

Asebotoxin IX

C25H38O8 (466.2567)


   

16(R)-6alpha,11beta-dihydroxy-17-methoxy-3beta,7beta-diacetoxy-ent-kaur-15-one|xindongnin G

16(R)-6alpha,11beta-dihydroxy-17-methoxy-3beta,7beta-diacetoxy-ent-kaur-15-one|xindongnin G

C25H38O8 (466.2567)


   

clerodinin A|clerodinin B|lupulin D|O15-De-Et,O15-Methyl,15-Epimer-Clerodinin C

clerodinin A|clerodinin B|lupulin D|O15-De-Et,O15-Methyl,15-Epimer-Clerodinin C

C25H38O8 (466.2567)


   

11,12-Di-O-acetyl-marsectohexol|11,12-di-O-acetylmarsectohexol|11.12-Di-O-acetyl-marsectohexol|12-O-acetyllanceogenin

11,12-Di-O-acetyl-marsectohexol|11,12-di-O-acetylmarsectohexol|11.12-Di-O-acetyl-marsectohexol|12-O-acetyllanceogenin

C25H38O8 (466.2567)


   

Asebotoxin-IX

Asebotoxin-IX

C25H38O8 (466.2567)


   

1,6,9-trihydroxy-3-(1-hydroxy-1-methylethyl)-10-isobutyryl-5,5-dimethyl-8-(3-methylbut-2-enyl)-4-oxabicyclo[6.3.1]dodec-9-ene-11,12-dione|garcinielliptone HF

1,6,9-trihydroxy-3-(1-hydroxy-1-methylethyl)-10-isobutyryl-5,5-dimethyl-8-(3-methylbut-2-enyl)-4-oxabicyclo[6.3.1]dodec-9-ene-11,12-dione|garcinielliptone HF

C25H38O8 (466.2567)


   

(1beta,2beta,3beta,4beta,6beta)-3,4-epoxybisabol-7(14)-ene-1,2,8,10,11-pentol 2,10-diangelate|(2Z)-2-methylbut-2-enoic acid (1RS,2SR,3SR,4RS,6RS)-4-(2,5-dihydroxy-5-methyl-1-methylene-4-{[(2Z)-2-methyl-1-oxobut-2-en-1-yl]oxy}hexyl)-3-hydroxy-1-methyl-7-oxabicyclo[4.1.0]hept-2-yl ester

(1beta,2beta,3beta,4beta,6beta)-3,4-epoxybisabol-7(14)-ene-1,2,8,10,11-pentol 2,10-diangelate|(2Z)-2-methylbut-2-enoic acid (1RS,2SR,3SR,4RS,6RS)-4-(2,5-dihydroxy-5-methyl-1-methylene-4-{[(2Z)-2-methyl-1-oxobut-2-en-1-yl]oxy}hexyl)-3-hydroxy-1-methyl-7-oxabicyclo[4.1.0]hept-2-yl ester

C25H38O8 (466.2567)


   

4-epi-aubergenone 11-O-2,3-di-O-acetyl-alpha-L-rhamnopyranoside

4-epi-aubergenone 11-O-2,3-di-O-acetyl-alpha-L-rhamnopyranoside

C25H38O8 (466.2567)


   

4-epi-aubergenone 11-O-2,4-di-O-acetyl-alpha-L-rhamnopyranoside

4-epi-aubergenone 11-O-2,4-di-O-acetyl-alpha-L-rhamnopyranoside

C25H38O8 (466.2567)


   

2beta,8-diangeloyloxy-3beta,4beta-epoxy-1beta,10,11-trihydroxybisabol-7(14)-ene

2beta,8-diangeloyloxy-3beta,4beta-epoxy-1beta,10,11-trihydroxybisabol-7(14)-ene

C25H38O8 (466.2567)


   

2beta,8-diangeloyloxy-1beta,3beta,4alpha,11-tetrahydroxybisabol-7(14),9-diene

2beta,8-diangeloyloxy-1beta,3beta,4alpha,11-tetrahydroxybisabol-7(14),9-diene

C25H38O8 (466.2567)


   

(rel-5S,6R,8R,9R,10S,13S,15R)-6-acetoxy-9,13:15,16-diepoxy-15-methoxylabdane|3alpha,8beta-diacetoxy-9,13;15,16-diepoxy-15beta-methoxylabdan-7-one|leosibirinone A

(rel-5S,6R,8R,9R,10S,13S,15R)-6-acetoxy-9,13:15,16-diepoxy-15-methoxylabdane|3alpha,8beta-diacetoxy-9,13;15,16-diepoxy-15beta-methoxylabdan-7-one|leosibirinone A

C25H38O8 (466.2567)


   

erinacine J

erinacine J

C25H38O8 (466.2567)


   

3α-hydroxy-5α-androstane-17-one 3-D-glucuronide

3α-hydroxy-5α-androstane-17-one 3-D-glucuronide

C25H38O8 (466.2567)


   

5-alpha-Dihydrotestosterone glucuronide

5-alpha-Dihydrotestosterone glucuronide

C25H38O8 (466.2567)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

3alpha-Hydroxy-5alpha-androstane-17-one 3-D-glucuronoside

3alpha-Hydroxy-5alpha-androstane-17-one 3-delta-glucuronoside

C25H38O8 (466.2567)


   

3alpha-hydroxy-5alpha-androstane-17-one 3-D-glucuronide

3alpha-hydroxy-5alpha-androstane-17-one 3-D-glucuronide

C25H38O8 (466.2567)


   

Sarcoehrendin F

methyl 18-oxo-9S,hydroxy-11R,15S-diacetoxy-5Z,13E-prostadienoate

C25H38O8 (466.2567)


   

ST 19:1;O2;GlcA

17beta-hydroxy-androstan-3-one 17-O-glucuronide

C25H38O8 (466.2567)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

butyl prop-2-enoate,2-methylprop-2-enoic acid,propane-1,2-diol,prop-2-enoic acid,styrene

butyl prop-2-enoate,2-methylprop-2-enoic acid,propane-1,2-diol,prop-2-enoic acid,styrene

C25H38O8 (466.2567)


   

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide

(3S,5R,6S)-6-{[(1S,2S,5R,7S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2567)


3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide is a natural human metabolite of 3-alpha-hydroxy-5-alpha-androstane-17-one generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide is a natural human metabolite of 3-alpha-hydroxy-5-alpha-androstane-17-one generated in the liver by UDP glucuonyltransferase.

   

5alpha-Androstan-17beta-ol-3-one glucosiduronate

6-({2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H38O8 (466.2567)


   

DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

DG(2:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C25H38O8 (466.2567)


   

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/2:0/0:0)

C25H38O8 (466.2567)


   

DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C25H38O8 (466.2567)


   

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/2:0)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/2:0)

C25H38O8 (466.2567)


   

Etiocholanolone 3-glucuronide

Etiocholanolone 3-glucuronide

C25H38O8 (466.2567)


A steroid glucosiduronic acid having etiocholanolone as the steroid component.

   

Glucosyl-6beta-hydroxytestosterone

Glucosyl-6beta-hydroxytestosterone

C25H38O8 (466.2567)


A steroid saponin that is 6beta-hydroxytestosterone attached to a alpha-D-glucopyranosyl residue at position 6 via glycosidic linkage.

   

Androsterone glucuronide

3alpha-hydroxy-5alpha-androstan-17-one 3-D-glucuronide

C25H38O8 (466.2567)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

Etiocholanolone glucuronide

3alpha-hydroxy-5beta-androstan-17-one 3-D-glucuronide

C25H38O8 (466.2567)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide

3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide

C25H38O8 (466.2567)


   

5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide)

5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide)

C25H38O8 (466.2567)


A steroid glucosiduronic acid that is 5alpha-dihydrotestosterone having a single beta-D-glucuronic acid residue attached at position 17.

   

androsterone 3-glucosiduronic acid

androsterone 3-glucosiduronic acid

C25H38O8 (466.2567)


A steroid glucosiduronic acid having androsterone as the steroid component.

   

3alpha-hydroxy-5beta-androstan-17-one 3-glucosiduronic acid

3alpha-hydroxy-5beta-androstan-17-one 3-glucosiduronic acid

C25H38O8 (466.2567)


   

ST 19:2;O3;Hex

ST 19:2;O3;Hex

C25H38O8 (466.2567)


   
   

4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

C25H38O8 (466.2567)


   

(1r,2r,4as,5'r,5''r,6r,8as)-6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

(1r,2r,4as,5'r,5''r,6r,8as)-6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C25H38O8 (466.2567)


   

(3s,3as,6as,9s,10r)-4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

(3s,3as,6as,9s,10r)-4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

C25H38O8 (466.2567)


   

(1r,2r,2''s,4r,4as,5's,6s,8as)-2''-(acetyloxy)-4-(formyloxy)-2,5,5,8a-tetramethyl-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

(1r,2r,2''s,4r,4as,5's,6s,8as)-2''-(acetyloxy)-4-(formyloxy)-2,5,5,8a-tetramethyl-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

C25H38O8 (466.2567)


   

(3s,5s)-5,6-dihydroxy-2-[(1r,3r,4s,5s,6s)-5-hydroxy-6-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-7-oxabicyclo[4.1.0]heptan-3-yl]-6-methylhept-1-en-3-yl (2z)-2-methylbut-2-enoate

(3s,5s)-5,6-dihydroxy-2-[(1r,3r,4s,5s,6s)-5-hydroxy-6-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-7-oxabicyclo[4.1.0]heptan-3-yl]-6-methylhept-1-en-3-yl (2z)-2-methylbut-2-enoate

C25H38O8 (466.2567)


   

(1s,2r,4as,5's,5''s,6r,8as)-6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

(1s,2r,4as,5's,5''s,6r,8as)-6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C25H38O8 (466.2567)


   

2''-(acetyloxy)-4-(formyloxy)-2,5,5,8a-tetramethyl-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

2''-(acetyloxy)-4-(formyloxy)-2,5,5,8a-tetramethyl-hexahydro-2h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-6-yl acetate

C25H38O8 (466.2567)


   

(1r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5r,6ar)-5-methoxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate

(1r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5r,6ar)-5-methoxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate

C25H38O8 (466.2567)


   

(1s,2r,5s,7s,10s,11s,13s,14r,17s,19r)-11,14,18-trihydroxy-2,5-dimethyl-5-(4-methyl-3-oxopentyl)-12,16,20-trioxapentacyclo[15.2.1.0²,⁷.0¹⁰,¹⁹.0¹³,¹⁸]icosan-6-one

(1s,2r,5s,7s,10s,11s,13s,14r,17s,19r)-11,14,18-trihydroxy-2,5-dimethyl-5-(4-methyl-3-oxopentyl)-12,16,20-trioxapentacyclo[15.2.1.0²,⁷.0¹⁰,¹⁹.0¹³,¹⁸]icosan-6-one

C25H38O8 (466.2567)


   

1,6,9-trihydroxy-3-(2-hydroxypropan-2-yl)-5,5-dimethyl-8-(3-methylbut-2-en-1-yl)-10-(2-methylpropanoyl)-4-oxabicyclo[6.3.1]dodec-9-ene-11,12-dione

1,6,9-trihydroxy-3-(2-hydroxypropan-2-yl)-5,5-dimethyl-8-(3-methylbut-2-en-1-yl)-10-(2-methylpropanoyl)-4-oxabicyclo[6.3.1]dodec-9-ene-11,12-dione

C25H38O8 (466.2567)


   

10-(acetyloxy)-3a,3b,7-trihydroxy-1-(1-hydroxyethyl)-9a,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate

10-(acetyloxy)-3a,3b,7-trihydroxy-1-(1-hydroxyethyl)-9a,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate

C25H38O8 (466.2567)


   

(1s,3ar,3bs,7s,9ar,9bs,10s,11s,11as)-10-(acetyloxy)-3a,3b,7-trihydroxy-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate

(1s,3ar,3bs,7s,9ar,9bs,10s,11s,11as)-10-(acetyloxy)-3a,3b,7-trihydroxy-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate

C25H38O8 (466.2567)


   

(1s,3r,6s,8s)-1,6,9-trihydroxy-3-(2-hydroxypropan-2-yl)-5,5-dimethyl-8-(3-methylbut-2-en-1-yl)-10-(2-methylpropanoyl)-4-oxabicyclo[6.3.1]dodec-9-ene-11,12-dione

(1s,3r,6s,8s)-1,6,9-trihydroxy-3-(2-hydroxypropan-2-yl)-5,5-dimethyl-8-(3-methylbut-2-en-1-yl)-10-(2-methylpropanoyl)-4-oxabicyclo[6.3.1]dodec-9-ene-11,12-dione

C25H38O8 (466.2567)


   

4-formyl-3,10-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl 2-hydroxydecanoate

4-formyl-3,10-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl 2-hydroxydecanoate

C25H38O8 (466.2567)


   

(3s,3as,6as,9s,10r,10ar)-4-formyl-3,10-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl (2r)-2-hydroxydecanoate

(3s,3as,6as,9s,10r,10ar)-4-formyl-3,10-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl (2r)-2-hydroxydecanoate

C25H38O8 (466.2567)


   

11,14,18-trihydroxy-2,5-dimethyl-5-(4-methyl-3-oxopentyl)-12,16,20-trioxapentacyclo[15.2.1.0²,⁷.0¹⁰,¹⁹.0¹³,¹⁸]icosan-6-one

11,14,18-trihydroxy-2,5-dimethyl-5-(4-methyl-3-oxopentyl)-12,16,20-trioxapentacyclo[15.2.1.0²,⁷.0¹⁰,¹⁹.0¹³,¹⁸]icosan-6-one

C25H38O8 (466.2567)


   

(3r,5r)-2,5-dihydroxy-6-[(1s,3s,4r,5r,6s)-4-hydroxy-6-methyl-5-{[(2z)-2-methylbut-2-enoyl]oxy}-7-oxabicyclo[4.1.0]heptan-3-yl]-2-methylhept-6-en-3-yl (2z)-2-methylbut-2-enoate

(3r,5r)-2,5-dihydroxy-6-[(1s,3s,4r,5r,6s)-4-hydroxy-6-methyl-5-{[(2z)-2-methylbut-2-enoyl]oxy}-7-oxabicyclo[4.1.0]heptan-3-yl]-2-methylhept-6-en-3-yl (2z)-2-methylbut-2-enoate

C25H38O8 (466.2567)


   

(1s,2r,5s,7s,10s,11s,13s,14r,17s,18s,19r)-11,14,18-trihydroxy-2,5-dimethyl-5-(4-methyl-3-oxopentyl)-12,16,20-trioxapentacyclo[15.2.1.0²,⁷.0¹⁰,¹⁹.0¹³,¹⁸]icosan-6-one

(1s,2r,5s,7s,10s,11s,13s,14r,17s,18s,19r)-11,14,18-trihydroxy-2,5-dimethyl-5-(4-methyl-3-oxopentyl)-12,16,20-trioxapentacyclo[15.2.1.0²,⁷.0¹⁰,¹⁹.0¹³,¹⁸]icosan-6-one

C25H38O8 (466.2567)


   

(1s,2r,4as,5's,5''r,6r,8as)-6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

(1s,2r,4as,5's,5''r,6r,8as)-6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C25H38O8 (466.2567)


   

2,5-dihydroxy-6-{4-hydroxy-6-methyl-5-[(2-methylbut-2-enoyl)oxy]-7-oxabicyclo[4.1.0]heptan-3-yl}-2-methylhept-6-en-3-yl 2-methylbut-2-enoate

2,5-dihydroxy-6-{4-hydroxy-6-methyl-5-[(2-methylbut-2-enoyl)oxy]-7-oxabicyclo[4.1.0]heptan-3-yl}-2-methylhept-6-en-3-yl 2-methylbut-2-enoate

C25H38O8 (466.2567)


   

5,6-dihydroxy-2-{5-hydroxy-6-methyl-4-[(2-methylbut-2-enoyl)oxy]-7-oxabicyclo[4.1.0]heptan-3-yl}-6-methylhept-1-en-3-yl 2-methylbut-2-enoate

5,6-dihydroxy-2-{5-hydroxy-6-methyl-4-[(2-methylbut-2-enoyl)oxy]-7-oxabicyclo[4.1.0]heptan-3-yl}-6-methylhept-1-en-3-yl 2-methylbut-2-enoate

C25H38O8 (466.2567)


   

6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

6-(acetyloxy)-5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate

C25H38O8 (466.2567)


   

(3s,3as,6as,9s,10r,10ar)-4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

(3s,3as,6as,9s,10r,10ar)-4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl 2-hydroxydecanoate

C25H38O8 (466.2567)


   

(3r,3ar,6ar,9r,10s,10as)-4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (2r)-2-hydroxydecanoate

(3r,3ar,6ar,9r,10s,10as)-4-formyl-3,9-dihydroxy-7,7-dimethyl-1-oxo-3h,3ah,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-10-yl (2r)-2-hydroxydecanoate

C25H38O8 (466.2567)